rs137919

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015166.4(MLC1):​c.*48A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 1,574,564 control chromosomes in the GnomAD database, including 71,742 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5259 hom., cov: 33)
Exomes 𝑓: 0.30 ( 66483 hom. )

Consequence

MLC1
NM_015166.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.84

Publications

11 publications found
Variant links:
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-50061535-T-C is Benign according to our data. Variant chr22-50061535-T-C is described in ClinVar as Benign. ClinVar VariationId is 262456.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.408 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLC1NM_015166.4 linkc.*48A>G 3_prime_UTR_variant Exon 12 of 12 ENST00000311597.10 NP_055981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLC1ENST00000311597.10 linkc.*48A>G 3_prime_UTR_variant Exon 12 of 12 1 NM_015166.4 ENSP00000310375.6
MLC1ENST00000395876.6 linkc.*48A>G 3_prime_UTR_variant Exon 12 of 12 1 ENSP00000379216.2
MLC1ENST00000483836.1 linkn.539A>G non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.245
AC:
37318
AN:
152078
Hom.:
5257
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.322
Gnomad ASJ
AF:
0.202
Gnomad EAS
AF:
0.344
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.239
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.290
Gnomad OTH
AF:
0.273
GnomAD2 exomes
AF:
0.299
AC:
74608
AN:
249194
AF XY:
0.308
show subpopulations
Gnomad AFR exome
AF:
0.106
Gnomad AMR exome
AF:
0.338
Gnomad ASJ exome
AF:
0.208
Gnomad EAS exome
AF:
0.337
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.287
GnomAD4 exome
AF:
0.301
AC:
428558
AN:
1422368
Hom.:
66483
Cov.:
27
AF XY:
0.305
AC XY:
216789
AN XY:
710018
show subpopulations
African (AFR)
AF:
0.106
AC:
3465
AN:
32594
American (AMR)
AF:
0.341
AC:
15212
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
5517
AN:
25934
East Asian (EAS)
AF:
0.357
AC:
14080
AN:
39472
South Asian (SAS)
AF:
0.415
AC:
35532
AN:
85546
European-Finnish (FIN)
AF:
0.255
AC:
13021
AN:
51038
Middle Eastern (MID)
AF:
0.288
AC:
1527
AN:
5308
European-Non Finnish (NFE)
AF:
0.300
AC:
323095
AN:
1078680
Other (OTH)
AF:
0.289
AC:
17109
AN:
59122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
16794
33589
50383
67178
83972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10580
21160
31740
42320
52900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
37331
AN:
152196
Hom.:
5259
Cov.:
33
AF XY:
0.247
AC XY:
18411
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.111
AC:
4617
AN:
41544
American (AMR)
AF:
0.322
AC:
4929
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
703
AN:
3472
East Asian (EAS)
AF:
0.345
AC:
1780
AN:
5162
South Asian (SAS)
AF:
0.423
AC:
2041
AN:
4824
European-Finnish (FIN)
AF:
0.239
AC:
2530
AN:
10604
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.290
AC:
19741
AN:
67982
Other (OTH)
AF:
0.271
AC:
572
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1492
2985
4477
5970
7462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.276
Hom.:
6873
Bravo
AF:
0.244
Asia WGS
AF:
0.362
AC:
1257
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:2
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.20
DANN
Benign
0.38
PhyloP100
-3.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137919; hg19: chr22-50499964; COSMIC: COSV61117386; COSMIC: COSV61117386; API